TuesdayMar 16, 2021 3:22 pm

QualityStocksNewsBreaks – Green Hygienics Holdings Inc. (GRYN) Announces Closing of Castillo Assets Acquisition

Green Hygienics Holdings (OTCQB: GRYN) today announced that it has closed the acquisition of certain assets of Castillo Seed LLC. (“Castillo”), a pioneering hemp seed company with an extensive library of proven genetics backed by years of research and development efforts. According to the update, the assets include seed inventories, thousands of stock plants, an established genetics portfolio, and greenhouse and seed production equipment. “We saw an opportunity to fast-track our genetics program by procuring a developed genetics portfolio, which will not only save 3-5 years of R&D work but also allow the company to propagate proprietary USDA Certified Organic…

Continue Reading

TuesdayMar 16, 2021 3:11 pm

Sharing Services Global Corp. (SHRG) New Branding Built Around Happiness and Well-Being Targets Key Shifts in Consumer Behavior

SHRG has launched new brand identity, the Happy Co. New brand designed to convey core values — happiness, family and community — reflecting emerging shift in consumer behavior Rebranding is part of wider strategy to accelerate international growth Sharing Services Global (OTCQB: SHRG), a publicly traded company specializing in the direct-selling industry and network marketing, has unveiled the new brand identity of its wholly owned subsidiaries Elevacity Holdings LLC and Elevacity U.S. LLC, now known as the Happy Co. (https://ibn.fm/XUyUg). "The Happy Co. is not just a name; it is the best descriptor of our mission. It directly mirrors our values…

Continue Reading

TuesdayMar 16, 2021 2:59 pm

SRAX Inc.’s (SRAX) Sequire Provides ‘Oil,’ Technology to Significantly Impact Companies’ Interaction with Investors

Big data is meaningless without technology to unlock, interpret value of information SRAX is on leading edge of offering essential data that can transform publicly held companies Sequire provides key insights that help companies track investors’ behaviors and trends, then use those insights to engage current, potential investors Data is the “oil” of the fourth industrial revolution, according to a recent “Forbes” article (https://ibn.fm/5msqb). The article, which took a close look at expected trends in big data and analytics this year, noted that many significant advancements seen in the world today would be impossible without data and the analytic technology…

Continue Reading

TuesdayMar 16, 2021 2:42 pm

QualityStocksNewsBreaks – Kaival Brands Innovations Group Inc. (KAVL) Releases Q1 Revenue, Gross Profit Numbers

Kaival Brands (OTCQB: KAVL), a company focused on generating shareholder value by incubating innovative products into mature and dominant brands within their respective markets, has reported its Q1 numbers for the period ending Jan. 31, 2021; the report notes first-quarter revenues of $37 million and gross profit totals of $4.8 million. In addition, the company announced that it had achieved cumulative revenue of $100 million in less than a year and has reconfirmed its FY2021 revenue guidance of $400 to $450 million. These revenue milestones were the best to date for Kaival Brands, which is the exclusive global distributor of…

Continue Reading

TuesdayMar 16, 2021 2:34 pm

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Set to Begin Enrolling Brain Cancer Drug Trial Participants

Brain cancer drug developer CNS Pharmaceuticals is finalizing preparations to begin March enrollment of patients in its potentially pivotal Phase 2 trial evaluating its promising lead candidate, Berubicin, for the overall survival improvement of glioblastoma (“GBM”) patients Glioblastomas are a type of brain cancer that have continued to elude effective therapy over the past century of investigation, leaving patients with expectations of approximately 15 months of survivability beyond diagnosis and recurrence after surgical removal A GBM patient in a small Phase 1 Berubicin safety trial 15 years ago has remained cancer-free and stable as of last November, a hint of…

Continue Reading

TuesdayMar 16, 2021 2:18 pm

TAAT Lifestyle & Wellness Ltd. (CSE: TAAT) (OTCQB: TOBAF) Announces the Beginning of Retail Rollout of Flagship Product

CPG partner starting TAAT rollout in Ohio, where three-quarters of CROSSMARK accounts indicate interest in carrying the cigarette alternative Company focused on capturing additional market share in $814 billion global tobacco industry CROSSMARK services 100,000-plus convenience stores across the country TAAT Lifestyle & Wellness Ltd. (CSE: TAAT) (OTCQB: TOBAF) has announced that its flagship product — TAAT(TM), a tobacco-free, nicotine-free cigarette — will be showing up on shelves across Ohio, with plans to expand outside the state soon after (https://ibn.fm/uzi6a). The increasing visibility of the popular product comes as a result of TAAT’s agreement with Texas-based CPG sales agency CROSSMARK to…

Continue Reading

TuesdayMar 16, 2021 1:50 pm

QualityStocksNewsBreaks – InsuraGuest Technologies Inc. (TSX.V: ISGI) (OTCQB: ISGIF) Unveils New Limited-Service Hospitality Liability Product

InsuraGuest Technologies (TSX.V: ISGI) (OTCQB: ISGIF), a leading U.S. insurance brokerage and consulting firm, has announced a new product: Limited-Service Hospitality Liability coverages. The product is offered through ISGI’s wholly owned U.S. subsidiary InsuraGuest RPG (“RPG”). The new product will be available to qualifying hotels, which are franchise limited-service hotels with less than 100 rooms and an average daily rate (“ADR”) under $100 a night. Of the 55,900-plus hotel properties in the United States, 33,000 are limited-service hotels, so the intended audience for the new service is impressive. ISGI’s property management system currently integrates with 82 different property management systems through…

Continue Reading

TuesdayMar 16, 2021 1:39 pm

QualityStocksNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Completes Enrollment in Upcoming Phase 2b Clinical Trial of Cystic Fibrosis Treatment

AzurRx BioPharma (NASDAQ: AZRX), a clinical-stage biopharmaceutical company specializing in the development of targeted, nonsystemic therapies for gastrointestinal (“GI”) diseases, has announced the completion of enrollment for its phase 2b OPTION 2 clinical trial to investigate MS1819 in cystic fibrosis (“CF”) patients with exocrine pancreatic insufficiency (“EPI”). According to the announcement, the company enrolled 30 CF patients for the study, which is anticipated to return top line data by the end of Q1 2021. The upcoming phase 2b, multicenter study will investigate the safety, tolerability and efficacy of MS1819 in a head-to-head comparison against the current porcine enzyme replacement therapy…

Continue Reading

TuesdayMar 16, 2021 1:20 pm

QualityStocksNewsBreaks – Sanwire Corp. (SNWR) Subsidiary Announces Partnership with Meridian Gates Entertainment

Sanwire (OTC: SNWR), a diversified company with a focus on technologies for the entertainment industry, has announced that the Meridian Gates Entertainment label has joined Intercept Music Inc.’s artist incubation program. Intercept Music is a wholly owned subsidiary of Sanwire, and Meridian Gates Entertainment is a production house and record label based in Miami, Florida. Top acts handled by Meridian Gates include Maxi Priest, Bunny Wailer, The Wailers and Buju Banton. Many of Meridian’s artists will be participating in the label incubator program as well as Intercept PLUS; the announcement noted that two-time Grammy nominee Maxi Priest would be the first act…

Continue Reading

TuesdayMar 16, 2021 1:01 pm

QualityStocksNewsBreaks – Healthtech Solutions Inc. (HLTT) Announces Incorporation of New RevHeart Inc. Subsidiary

Healthtech Solutions (OTC: HLTT), parent company of Medi-Scan Inc., today announced the incorporation of a new subsidiary called RevHeart Inc. According to the update, the new subsidiary will conduct further research into finding a treatment for COVID-related heart muscle injury. In direct support of the company’s ongoing efforts, RevHeart’s research team is developing the ability to identify and track myocardial deformities to enable implementation of a therapy to ameliorate and potentially repair myocardial damage. Based on positive results to date, RevHeart has filed a provisional patent application with the U.S. Patent and Trademark Office titled, "System, Method and Apparatus for…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered